Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Autonomix MedicalAMIX -9.67%15 Net Cash per Share is $9.76 as of Mar. 2026, which is 1062% above its 10-year median of 0.84. GuruFocus rates AMIX with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 300 Medical Devices & Instruments companies, Autonomix Medical ranks better than 98.67% on this metric.
The historical rank and industry rank for Autonomix Medical's Net Cash per Share or its related term are showing as below:
AMIX'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.37 Med: 0.84 Max: 8.36
Current: 0.37
During the past 4 years, the highest Price-to-Net-Cash Ratio of Autonomix Medical was 8.36. The lowest was 0.37. And the median was 0.84.
AMIX's Price-to-Net-Cash is ranked better than 98.67% of 300
companies
in the Medical Devices & Instruments industry
Industry Median: 7.575
vs AMIX: 0.37
Autonomix Medical (NAS:AMIX) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Autonomix Medical Net Cash per Share Related Terms
Autonomix Medical Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Autonomix Medical's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMIX vs BJDX, LUDG, ALURD: Net Cash per Share Comparison
For the Medical Devices subindustry, Autonomix Medical's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Autonomix Medical Price-to-Net-Cash vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Autonomix Medical's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Autonomix Medical's Net Cash per Share for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Autonomix Medical (AMIX) has a Net Cash per Share of $9.76 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Autonomix Medical and its competitors. This is 1062% above median its historical median of 0.84. Over the past decade, Autonomix Medical's Net Cash per Share has ranged from 0.37 to 8.36. According to the industry distribution chart, Autonomix Medical ranks #4 out of 300 companies in the Medical Devices & Instruments industry, placing it in the top 1.3%.
Is Autonomix Medical's Net Cash per Share too high?
Autonomix Medical's current Net Cash per Share of $9.76 is 1062% above median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 8.36. The Medical Devices & Instruments industry median Net Cash per Share is 7.58. Autonomix Medical's value of $9.76 is 28.8% above this industry median. Based on the distribution chart, Autonomix Medical ranks #4 out of 300 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Autonomix Medical has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Autonomix Medical's Net Cash per Share compare to BJDX and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Autonomix Medical ranks #4 out of 300 companies for Net Cash per Share. This places Autonomix Medical in the top 1% of its industry — outperforming the majority of peers. The industry median Net Cash per Share is 7.58. Autonomix Medical's value of $9.76 is 28.8% above this benchmark. Historically, Autonomix Medical's own Net Cash per Share has ranged from 0.37 to 8.36 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 7.58, Autonomix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Devices & Instruments company?
The median Net Cash per Share among Medical Devices & Instruments companies is 7.58, based on 300 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Autonomix Medical's current Net Cash per Share of $9.76 is 28.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Autonomix Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Cash per Share is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Autonomix Medical's current Net Cash per Share is $9.76, which is 1062% above median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autonomix Medical stock overvalued right now?
Autonomix Medical (AMIX) has a current Net Cash per Share of $9.76. The current Net Cash per Share is $9.76, which is 1062% above median its 10-year median of 0.84 and 28.8% above the Medical Devices & Instruments industry median of 7.58. Autonomix Medical's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Autonomix Medical (AMIX), the current Net Cash per Share is $9.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
15GF Score
Get the complete analysis for AMIX
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMIX has been successfully added to your 
